David Hodgson

Also affiliated with The University of Texas MD Anderson Cancer Center, University of Toronto, Hospital for Sick Children, Princess Margaret Cancer Centre

MedicinePhysics and Astronomy

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 6%percentile

0.208Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Accelerating pediatric Hodgkin lymphoma research: the Hodgkin Lymphoma Data Collaboration (NODAL)

JNCI Journal of the National Cancer Institute(2024)10.1093/jnci/djae013

Top 65%

0.208DataRank

Top 65%3 citations

Suzi Birz, Sharon M. Castellino, Tara O. Henderson, John T. Lucas, Qinglin Pei +36 more

Papers

Driven by 24 papers — median percentile 35. Top paper: “Brentuximab Vedotin with Chemotherapy in Pediatric High-Risk Hodgkin’s Lymphoma”.

Brentuximab Vedotin with Chemotherapy in Pediatric High-Risk Hodgkin’s Lymphoma

New England Journal of Medicine(2022)10.1056/nejmoa2206660

N/A

3.7DataRank · unranked

170 citations

Qinglin Pei, Susan K. Parsons, David Hodgson, Kathleen M. McCarten, Terzah M. Horton +10 more

Nivolumab+AVD in Advanced-Stage Classic Hodgkin’s Lymphoma

New England Journal of Medicine(2024)10.1056/nejmoa2405888

N/A

3.4DataRank · unranked

211 citations

Michael LeBlanc, Sharon M. Castellino, Hongli Li, Sarah C. Rutherford, Andrew M. Evens +42 more

Targeted radiotherapy for early-stage, low-risk pediatric Hodgkin lymphoma slow early responders: a COG AHOD0431 analysis

Blood(2022)10.1182/blood.2022016098

N/A

0.531DataRank · unranked

14 citations

Frank G. Keller, Kathleen M. McCarten, Sandy Kessel, Steve Cho, Qinglin Pei +8 more

NIVOLUMAB(N)‐AVD IMPROVES PROGRESSION‐FREE SURVIVAL COMPARED TO BRENTUXIMAB VEDOTIN(BV)‐AVD IN ADVANCED STAGE (AS) CLASSIC HODGKIN LYMPHOMA (HL): RESULTS OF SWOG S1826

Hematological Oncology(2023)10.1002/hon.3163_5

N/A

0.464DataRank · unranked

21 citations

Michael LeBlanc, Sharon M. Castellino, Huilin Li, Sarah C. Rutherford, Andrew M. Evens +41 more

Radiation Dose-Volume-Response Relationships for Adverse Events in Childhood Cancer Survivors: Introduction to the Scientific Issues in PENTEC

International Journal of Radiation Oncology*Biology*Physics(2024)10.1016/j.ijrobp.2023.11.028

N/A

0.345DataRank · unranked

9 citations

Ivan R. Vogelius, David Hodgson, Rebecca M. Howell, W. Andrew Jackson, Chia‐Ho Hua +7 more

Importance of Central Imaging Review in a Pediatric Hodgkin Lymphoma Trial Using Positron Emission Tomography Response Adapted Radiation Therapy

International Journal of Radiation Oncology*Biology*Physics(2023)10.1016/j.ijrobp.2023.02.020

N/A

0.330DataRank · unranked

7 citations

Kathleen M. McCarten, Qinglin Pei, Sandy Kessel, Adina Alazraki, Joyce Mhlanga +12 more

Comparison of Contemporary Radiation Therapy Approaches in Combined Modality Treatment on Pediatric High-Risk Classic Hodgkin Lymphoma Study: AHOD 1331

International Journal of Radiation Oncology*Biology*Physics(2025)10.1016/j.ijrobp.2025.06.3876

N/A

0.292DataRank · unranked

6 citations

Raymond B. Mailhot Vega, Lindsay A. Renfro, Qinglin Pei, Anne-Marie Charpentier, Rahul R. Parikh +15 more

Accelerating pediatric Hodgkin lymphoma research: the Hodgkin Lymphoma Data Collaboration (NODAL)

JNCI Journal of the National Cancer Institute(2024)10.1093/jnci/djae013

Top 65%

0.208DataRank

Top 65%3 citations

Suzi Birz, Sharon M. Castellino, Tara O. Henderson, John T. Lucas, Qinglin Pei +36 more

Baseline metabolic tumour burden improves risk stratification in Hodgkin lymphoma: A Children's Oncology Group study

British Journal of Haematology(2023)10.1111/bjh.18734

N/A

0DataRank · unranked

16 citations

Ji‐Hyun Kim, Qinglin Pei, Inki Lee, Bradford S. Hoppe, Yue Wu +9 more

Radiation target nomenclature for lymphoma trials: consensus recommendations from the National Clinical Trials Network groups

The Lancet Haematology(2024)10.1016/s2352-3026(24)00276-x

N/A

0DataRank · unranked

11 citations

Chelsea C. Pinnix, Leslie K. Ballas, Chris R. Kelsey, Sarah A. Milgrom, Stephanie A. Terezakis +10 more

Radiation Therapy Technology Advances and Mitigation of Subsequent Neoplasms in Childhood Cancer Survivors

International Journal of Radiation Oncology*Biology*Physics(2024)10.1016/j.ijrobp.2024.01.206

N/A

0DataRank · unranked

8 citations

Neige Journy, Ivan R. Vogelius, Rebecca M. Howell, David Hodgson, Søren M. Bentzen +1 more

Evaluation of the Childhood Hodgkin International Prognostic Score (CHIPS) in High‐Risk Pediatric Hodgkin Lymphoma Patients Treated on Children's Oncology Group AHOD1331

Pediatric Blood & Cancer(2025)10.1002/pbc.31856

N/A

0DataRank · unranked

1 citations

Lindsay A. Renfro, Frank G. Keller, David Hodgson, Angela Punnett, Kathleen M. McCarten +6 more

126 | THE EARLY‐STAGE CLASSIC HODGKIN LYMPHOMA INTERNATIONAL PROGNOSTICATION INDEX (E‐HIPI): AN INDIVIDUALIZED PREDICTION MODEL UTILIZING OBJECTIVE AND CONTINUOUS VARIABLES

Hematological Oncology(2025)10.1002/hon.70093_126

N/A

0DataRank · unranked

0 citations

Angie May Rodday, Matthew J. Maurer, Jenica Upshaw, Nicholas Counsell, Sabrina Rossetti +19 more

Group-based trajectories of health-related quality of life among pediatric patients with high-risk Hodgkin lymphoma

JNCI Journal of the National Cancer Institute(2025)10.1093/jnci/djaf197

N/A

0DataRank · unranked

0 citations

Angie Mae Rodday, Lindsay A. Renfro, Yue Wu, Tara O. Henderson, Frank G. Keller +6 more

Enhancing Radiotherapy Quality Assurance in Lymphoma: A Rigorous Real-Time Central Review Process

International Journal of Radiation Oncology*Biology*Physics(2025)10.1016/j.ijrobp.2025.06.3203

N/A

0DataRank · unranked

0 citations

S.A. Milgrom, Raymond B. Mailhot Vega, David Hodgson, Henry Chapman, Sandra Kessel +15 more

A Randomized Phase IIb Study of Low-dose Tamoxifen in Chest-irradiated Cancer Survivors at Risk for Breast Cancer

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-3609

N/A

0DataRank · unranked

20 citations

Melanie R. Palomares, Lindsey Hageman, Yanjun Chen, Wendy Landier, Kandice Smith +17 more

Multimodality Artificial Intelligence for Involved-Site Radiation Therapy: Clinical Target Volume Delineation in High-Risk Pediatric Hodgkin Lymphoma

International Journal of Radiation Oncology*Biology*Physics(2025)10.1016/j.ijrobp.2025.12.005

N/A

0DataRank · unranked

0 citations

Sarah A. Milgrom, Andrea Lo, Anne-Marie Charpentier, Michael J. LaRiviere, Danyal Maqbool +7 more

Dose-volume effects of breast cancer radiation therapy on the risk of second oesophageal cancer

Radiotherapy and Oncology(2020)10.1016/j.radonc.2020.07.022

N/A

0DataRank · unranked

25 citations

Sara J. Schonfeld, Michael Hauptmann, Sander Roberti, Rebecca M. Howell, Susan A. Smith +9 more

An intergroup collaboration for advanced stage classical Hodgkin lymphoma (cHL) in adolescents and young adults (AYA): SWOG S1826.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.tps8067

N/A

0DataRank · unranked

8 citations

Michael LeBlanc, Alex F. Herrera, Susan K. Parsons, Angela Punnett, David Hodgson +8 more

Survival by age in paediatric and adolescent patients with Hodgkin lymphoma: a retrospective pooled analysis of children's oncology group trials

The Lancet Haematology(2021)10.1016/s2352-3026(21)00349-5

N/A

0DataRank · unranked

37 citations

Qinglin Pei, Debra L Friedman, Joel Kaplan, Frank G Keller, David Hodgson +8 more

Brentuximab vedotin and association with event-free survival (EFS) in children with newly diagnosed high-risk Hodgkin lymphoma (HL): A report from the Children's Oncology Group phase 3 study AHOD1331 (NCT 02166463).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.7504

N/A

0DataRank · unranked

5 citations

Qinglin Pei, Susan K. Parsons, David Hodgson, Kathleen M. McCarten, Angela Punnett +9 more

Cardiac Disease in Childhood Cancer Survivors Treated With Radiation Therapy: A PENTEC Comprehensive Review

International Journal of Radiation Oncology*Biology*Physics(2023)10.1016/j.ijrobp.2023.03.045

N/A

0DataRank · unranked

31 citations

T. Rancati, Homa Keshavarz, Giovanna Gagliardi, Marianne Aznar, Rebecca M. Howell +11 more

A User's Guide and Summary of Pediatric Normal Tissue Effects in the Clinic (PENTEC): Radiation Dose-Volume Response for Adverse Effects After Childhood Cancer Therapy and Future Directions

International Journal of Radiation Oncology*Biology*Physics(2023)10.1016/j.ijrobp.2023.09.005

N/A

0DataRank · unranked

24 citations

Lawrence B. Marks, Michael T. Milano, Cécile M. Ronckers, Andrew Jackson, Melissa M. Hudson +9 more

Proton Therapy Mediates Dose Reductions to Brain Structures Associated With Cognition in Children With Medulloblastoma

International Journal of Radiation Oncology*Biology*Physics(2023)10.1016/j.ijrobp.2023.11.035

N/A

0DataRank · unranked

18 citations

Lisa S. Kahalley, Donald Mabbott, David R. Grosshans, Anna Santiago, Arnold Paulino +16 more

David Hodgson

Indexed papers

Top data-sharing exemplar

Papers